Issn 2226-3551 Қазақстан Республикасының Валеология Академиясы
ВОПРОСЫ ЭКСПЕРИМЕНТАЛЬНОЙ И КЛИНИЧЕСКОЙ МЕДИЦИНЫ
жүктеу/скачать 3.45 Mb. Pdf көрінісі
|
| ВОПРОСЫ ЭКСПЕРИМЕНТАЛЬНОЙ И КЛИНИЧЕСКОЙ МЕДИЦИНЫ
111 Database of Systematic Reviews 2008, Issue 2. Art. No.: CD006178. DOI: 10.1002/14651858.CD006178. pub2. 26. Stacey D, Bennett CL, Barry MJ, Col NF, Eden KB, Holmes-Rovner M, Llewellyn-Thomas H, Lyddiatt A, Légaré F, Thomson R. Decision aids for people facing health treatment or screening decisions. Cochrane Database of Systematic Reviews 2011, Issue 10. Art. No.: CD001431. DOI: 10.1002/14651858. CD001431.pub3. 27. Gekas J et all. Rapid testing versus karyotyping in Down’s syndrome screening: cost-effectiveness and detection of clinically significant chromosome abnormalities. European Journal of Human Genetics (2011) 19, 3–9 28. Imataka G, Arisaka O. Chromosome analysis using spectral karyotyping (SKY). Cell Biochem Biophys. 2012 Jan;62(1):13-7. 29. Twisk M, Mastenbroek S, van Wely M, Heineman MJ, Van der Veen F, Repping S. Preimplantation genetic screening for abnormal number of chromosomes (aneuploidies) in in vitro fertilisation or intracytoplasmic sperm injection. Cochrane Database of Systematic Reviews 2006, Issue 1. Art. No.: CD005291. DOI: 10.1002/14651858. CD005291.pub2. 30. Grimshaw GM et all. Evaluation of molecular tests for prenatal diagnosis of chromosome Abnormalities. Health Technology Assessment 2003; Vol. 7: No. 10. 31. Wildschut H, Both MI, Medema S, Thomee E, Wildhagen MF, Kapp N. Medical methods for mid-trimester termination of pregnancy. Cochrane Database of Systematic Reviews 2011, Issue 1. Art. No.: CD005216. DOI: 10.1002/14651858.CD005216. pub2. 32. Fan HCh et all. Non-invasive prenatal measurement of the fetal genome. Nature, 2012, 487, 320–324 33. Perry J, White SM, Nouri S, Bain ShM, Hutchinson RhG, La Ph, Northrop E, Eyre HJ, Pertile MD, Hocking TA, Thompson EM, Yu S, Choo KHA, Slater HR. Unstable Robertsonian Translocations der(13;15)(q10;q10): Heritable Chromosome Fission Without Phenotypic Effect in Two Kindreds. American Journal of Medical Genetics 2005, 136A:25–30 34. Moutton S, Rooryck C, Toutain J, Cailley D, Bouron J, Villega F, Taupiac E, Lacombe D, Arveiler B, Goizet C. Dysmorphic features in subtelomeric 20p13 deletion excluding JAG1: A recognizable microdeletion phenotype? European Journal of Medical Genetics 55 (2012) 151e155 35. Shaffer LG, Theisen A, Bejjani BA, Ballif BC, Aylsworth AS, Lim C, McDonald M, Ellison JW, Kostiner D, Saitta S, Shaikh T. The discovery of microdeletion syndromes in the post-genomic era: review of the methodology and characterization of a new 1q41q42 microdeletion syndrome. Genet Med. 2007 Sep;9(9):607-16. 36. Pang EY-T, Bai AH-C, Ka-Fai To, Sy ShM-H, Wong NL-Y, Lai PB-S, Squire JA, Wong N. Identification of PFTAIRE Protein Kinase 1, a Novel Cell Division Cycle-2 Related Gene, in the Motile Phenotype of Hepatocellular Carcinoma Cells. Hepatology 2007;46:436-445. жүктеу/скачать 3.45 Mb. Достарыңызбен бөлісу:
|